Thus, IL-2 expansion of CD4+ Treg cells in HIV patients could not be expected to cure the deficit in conventional T cells seen in this disease nor contribute to decreasing the incidence of opportunistic infections and AIDS or non-AIDS-related malignancies. This evidence concerns the gene CD4 and AIDS.